Neuberger Berman Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.09M | Sell |
27,640
-2,095
| -7% | -$689K | 0.01% | 865 |
|
|
2025
Q4 | $10.4M | Sell |
29,735
-46,289
| -61% | -$15.6M | 0.01% | 795 |
|
|
2025
Q3 | $24.6M | Sell |
76,024
-7,773
| -9% | -$2.42M | 0.02% | 613 |
|
|
2025
Q2 | $32.6M | Sell |
83,797
-1,749
| -2% | -$703K | 0.03% | 530 |
|
|
2025
Q1 | $37.2M | Sell |
85,546
-158,016
| -65% | -$63.4M | 0.03% | 497 |
|
|
2024
Q4 | $89.8M | Sell |
243,562
-457,744
| -65% | -$192M | 0.07% | 318 |
|
|
2024
Q3 | $365M | Sell |
701,306
-217,883
| -24% | -$116M | 0.28% | 83 |
|
|
2024
Q2 | $498M | Buy |
919,189
+25,817
| +3% | +$13.6M | 0.41% | 43 |
|
|
2024
Q1 | $463M | Buy |
893,372
+166,261
| +23% | +$82.7M | 0.38% | 51 |
|
|
2023
Q4 | $343M | Buy |
727,111
+220,694
| +44% | +$102M | 0.3% | 76 |
|
|
2023
Q3 | $221M | Buy |
506,417
+710
| +0.1% | +$322K | 0.2% | 136 |
|
|
2023
Q2 | $225M | Buy |
505,707
+37,545
| +8% | +$17.3M | 0.2% | 131 |
|
|
2023
Q1 | $215M | Sell |
468,162
-466,848
| -50% | -$222M | 0.2% | 140 |
|
|
2022
Q4 | $480M | Buy |
935,010
+35,974
| +4% | +$18.3M | 0.47% | 40 |
|
|
2022
Q3 | $409M | Buy |
899,036
+34,356
| +4% | +$16.4M | 0.43% | 43 |
|
|
2022
Q2 | $417M | Buy |
864,680
+168,563
| +24% | +$83.4M | 0.42% | 44 |
|
|
2022
Q1 | $342M | Buy |
696,117
+57,948
| +9% | +$26.5M | 0.29% | 82 |
|
|
2021
Q4 | $291M | Buy |
638,169
+144,759
| +29% | +$60.9M | 0.23% | 116 |
|
|
2021
Q3 | $181M | Buy |
493,410
+58,222
| +13% | +$22.1M | 0.16% | 187 |
|
|
2021
Q2 | $164M | Buy |
435,188
+20,236
| +5% | +$7.73M | 0.14% | 224 |
|
|
2021
Q1 | $149M | Sell |
414,952
-7,805
| -2% | -$2.51M | 0.14% | 216 |
|
|
2020
Q4 | $136M | Buy |
422,757
+60,661
| +17% | +$18.6M | 0.14% | 212 |
|
|
2020
Q3 | $97.2M | Sell |
362,096
-17,247
| -5% | -$4.64M | 0.12% | 245 |
|
|
2020
Q2 | $99.7M | Buy |
379,343
+6,518
| +2% | +$1.74M | 0.12% | 227 |
|
|
2020
Q1 | $84.6M | Buy |
372,825
+50,239
| +16% | +$13.7M | 0.13% | 217 |
|
|
2019
Q4 | $97.4M | Sell |
322,586
-82,198
| -20% | -$22.6M | 0.11% | 257 |
|
|
2019
Q3 | $97.2M | Sell |
404,784
-20,683
| -5% | -$5.67M | 0.12% | 252 |
|
|
2019
Q2 | $120M | Sell |
425,467
-42,446
| -9% | -$11.6M | 0.14% | 201 |
|
|
2019
Q1 | $134M | Buy |
467,913
+16,180
| +4% | +$4.68M | 0.16% | 181 |
|
|
2018
Q4 | $119M | Sell |
451,733
-59,925
| -12% | -$16.5M | 0.17% | 190 |
|
|
2018
Q3 | $140M | Sell |
511,658
-8,740
| -2% | -$2.27M | 0.16% | 190 |
|
|
2018
Q2 | $124M | Buy |
520,398
+92,582
| +22% | +$21.4M | 0.14% | 221 |
|
|
2018
Q1 | $94M | Sell |
427,816
-15,217
| -3% | -$3.57M | 0.11% | 264 |
|
|
2017
Q4 | $99.8M | Buy |
443,033
+54,980
| +14% | +$11.7M | 0.11% | 265 |
|
|
2017
Q3 | $73.7M | Sell |
388,053
-60,688
| -14% | -$11.6M | 0.09% | 309 |
|
|
2017
Q2 | $84.4M | Buy |
448,741
+1,609
| +0.4% | +$289K | 0.11% | 279 |
|
|
2017
Q1 | $73.9M | Sell |
447,132
-6,823
| -2% | -$1.09M | 0.1% | 305 |
|
|
2016
Q4 | $65.3M | Buy |
453,955
+43,438
| +11% | +$5.82M | 0.09% | 327 |
|
|
2016
Q3 | $51.4M | Sell |
410,517
-83,593
| -17% | -$10.8M | 0.07% | 371 |
|
|
2016
Q2 | $64.9M | Sell |
494,110
-41,043
| -8% | -$5.62M | 0.09% | 301 |
|
|
2016
Q1 | $74.4M | Sell |
535,153
-20,351
| -4% | -$2.72M | 0.1% | 276 |
|
|
2015
Q4 | $77.5M | Buy |
555,504
+5,294
| +1% | +$729K | 0.1% | 275 |
|
|
2015
Q3 | $77M | Sell |
550,210
-95,851
| -15% | -$14.4M | 0.1% | 282 |
|
|
2015
Q2 | $106M | Sell |
646,061
-35,920
| -5% | -$5.74M | 0.12% | 250 |
|
|
2015
Q1 | $105M | Sell |
681,981
-12,345
| -2% | -$1.76M | 0.11% | 264 |
|
|
2014
Q4 | $87.3M | Sell |
694,326
-13,999
| -2% | -$1.73M | 0.09% | 301 |
|
|
2014
Q3 | $84.7M | Buy |
708,325
+517
| +0.1% | +$59.3K | 0.09% | 314 |
|
|
2014
Q2 | $76.2M | Sell |
707,808
-40,125
| -5% | -$4.13M | 0.07% | 358 |
|
|
2014
Q1 | $74.5M | Buy |
747,933
+10,982
| +1% | +$993K | 0.08% | 354 |
|
|
2013
Q4 | $68.1M | Buy |
736,951
+14,924
| +2% | +$1.33M | 0.07% | 376 |
|
|
2013
Q3 | $60.4M | Buy |
722,027
+18,188
| +3% | +$1.56M | 0.07% | 376 |
|
|
2013
Q2 | $57.6M | Buy |
+703,839
| New | +$52.7M | 0.07% | 362 |
|
Other funds holding ELV
VCM
VPM
Neuberger Berman Group's ELV Position: Q1 2026 in Review
Neuberger Berman Group reduced its Elevance Health (ELV) stake by 7% in Q1 2026, selling an estimated $689K and leaving 27,640 shares worth $8.09M. The position accounts for 0.01% of the portfolio, ranked #865.
Neuberger Berman Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $498M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Neuberger Berman Group held 27,640 shares of Elevance Health worth $8.09M as of Q1 2026.
- Neuberger Berman Group sold 2,095 Elevance Health shares in Q1 2026, an estimated $689K.
- Elevance Health made up 0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #865 holding.
- Neuberger Berman Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Elevance Health position peaked at $498M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.